Ixabepilone is a synthetic epothilone B analog and a microtubule-stabilizing antineoplastic agent approved for the treatment of advanced or metastatic breast cancer. Because precise quality control is… Read more
![Chemical structure of (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12-tetramethyl-3-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F219989-85-2-1S3S7S10R11S12S16R-711-Dihydroxy-881012-tetramethyl-3-E-1-2-methylthiazol-4-ylprop-1-en-2-yl-17-oxa-4-azabicyclo14.1.0heptadecane-59-dione.png&w=3840&q=75)






Ixabepilone is a synthetic epothilone B analog and a microtubule-stabilizing antineoplastic agent approved for the treatment of advanced or metastatic breast cancer. Because precise quality control is vital in pharmaceutical manufacturing, this category offers essential reference standards, including the active pharmaceutical ingredient, process-related impurities, and degradation products. These materials are fundamental for robust impurity profiling and method validation, enabling laboratories to accurately characterize complex chemical profiles. Furthermore, the inclusion of stable isotope labelled compounds allows for highly specific quantitative analysis using mass spectrometry techniques, ensuring accuracy in bioanalytical assays. Researchers also utilize system suitability mixtures to verify the resolution and performance of high-performance liquid chromatography methods, facilitating the consistent detection of impurities and ensuring that the final drug product meets stringent regulatory and safety requirements.